Gingivitis and periodontal diseases. Gingivitis and periodontal diseases
Conditions
Interventions
Intervention 1: Intervention group: First intervention group: Chlorhexidine (CHX) 0.2% mouthwash, used twice a day for 30 days, 10 ml for 30 seconds each time. Intervention 2: Intervention group: The
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 30 Years
Inclusion criteria
Inclusion criteria: The patient is undergoing fixed orthodontic treatment, at least 3 months have passed since the beginning of the treatment The brackets are placed with Adhesive Light Cure Patients are caries free Patients have not used any mouthwash in the last 3 months Placement of brackets should be correct and standard Consumption of tea, coffee and cocoa milk should be between 1 and 3 cups per day
Exclusion criteria
Exclusion criteria: People with systemic problems such as diabetes, hypothyroidism or hyperthyroidism and cancer Presence of dental problems such as fluorosis Pregnancy Habit of smoking Poor dental hygiene during the study period History of periodontal treatment up to 3 months before the start of the study History of using drugs that cause tooth discoloration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plaque Index (PI) based on Loe and Silness criteria. Timepoint: The beginning of the study (t0), 15 days (t1) and 30 days (t2) after the start of the study. Method of measurement: Clinical examination and scoring based on the Loe and Silness criteria.;Gingival Index (GI) based on Loe and Silness criteria. Timepoint: The beginning of the study (t0), 15 days (t1) and 30 days (t2) after the start of the study. Method of measurement: Clinical examination and scoring based on the Loe and Silness criteria.;Probing depth (PD). Timepoint: The beginning of the study (t0), 15 days (t1) and 30 days (t2) after the start of the study. Method of measurement: Periodontal probe.;Bleeding on Probing (BOP) based on Loe and Silness criteria. Timepoint: The beginning of the study (t0), 15 days (t1) and 30 days (t2) after the start of the study. Method of measurement: Clinical examination and scoring based on the Loe and Silness criteria.;Staining. Timepoint: The beginning of the study (t0), 15 days (t1) and 30 days (t2) after the start of the study. Method of measurement: Clinical examination and scoring based on Loben technique. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasim Rasouli
Ghoum University of Medical Sciences
Outcome results
None listed